Abstract
Obsessive-compulsive symptoms among youth with Prader-Willi Syndrome (PWS) are frequently present and associated with considerable problems in the daily functioning of the child and his/her family. Although pharmacological and psychosocial treatments exist that target obsessive-compulsive symptoms among typically developing youth, these treatments have not been systematically adapted and/or evaluated for this population. Furthermore, although psychotropic medications have shown promising support in addressing obsessive-compulsive symptoms in several case reports involving youth with PWS, associated efficacy is modest and potential for side effects is a realistic concern. Given efficacy and tolerability of cognitive-behavioral treatment for obsessive-compulsive symptoms in typically developing youth, an adapted version of this approach may hold promise in treating clinically problematic obsessive-compulsive symptoms in youth with PWS. Thus, we report on a case series of behavioral treatment for obsessive-compulsive symptoms in three youth with PWS. Diagnostic and symptom severity assessments were conducted at screening, pre-treatment, and post-treatment by a trained independent evaluator. All youth were considered treatment responders and exhibited meaningful reductions in compulsion severity, overall obsessive-compulsive severity, and obsessive-compulsive related impairment. These data provide preliminary evidence for the utility of behavioral therapy in treating obsessive-compulsive symptoms in youth with PWS.
Similar content being viewed by others
References
Abramowitz, J. A., Whiteside, S., & Deacon, B. (2005). The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behavior Therapy, 36, 55–63.
Benjamin, E., & Buot-Smith, T. (1993). Naltrexone and fluoxetine in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 870–873.
Clark, D. J., Boer, H., Whittington, J., Holland, A., Butler, J., & Webb, T. (2002). Prader-Willi syndrome, compulsive and ritualistic behaviors: the first population based survey. The British Journal of Psychiatry, 180, 358–362.
Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. Journal of the American Medical Association, 302, 1765–1773.
Dech, B., & Budow, L. (1991). The use of fluoxetine in an adolescent with Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 298–302.
Dimitropoulos, A., Feurer, I. D., Butler, M., & Thompson, T. (2001). Emergence of compulsive behaviors and tantrums in children with Prader-Willi syndrome. American Journal of Mental Retardation, 106, 39–51.
Dimitropoulos, A., Blackford, J., Walden, T., & Thompson, T. (2006). Compulsive behavior in Prader-Willi syndrome: examining severity in early childhood. Research in Developmental Disabilties, 27, 190–202.
Dykens, E. M., & Shah, B. (2003). Psychiatric disorders in Prader–Willi syndrome: epidemiology and management. CNS Drugs, 17, 167–178.
Dykens, E. M., Leckman, J. F., & Cassidy, S. B. (1996). Obsessions and compulsions in Prader-Willi Syndrome. Journal of Child Psychology and Psychiatry, 37, 995–1002.
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., et al. (2005). Randomized placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. The American Journal of Psychiatry, 162, 151–161.
Guy, W. (1976). Assessment manual for psychopharmacology, revised (DHEW publication ABM 76–366). US Government Printing Office: Washington D.C.
Hellings, J. A., & Warnock, J. K. (1994). Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacology Bulletin, 30, 245–250.
Hergüner, S., & Mukaddes, N. M. (2007). Psychosis associated with fluoxetine in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 944–945.
Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., et al. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version: initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 980–988.
Khanna, M. S., & Kendall, P. C. (2008). Computer-assisted CBT for child anxiety: the coping Cat CD-ROM. Cognitive and Behavioural Practice, 15, 159–165.
Kim, J. W., Yoo, H. J., Cho, S. C., Hong, K. E. M., & Kim, B. N. (2005). Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls. Journal of Child Neurology, 20, 134–138.
March, S., Spence, S. H., & Donovan, C. L. (2009). The efficacy of an internet-based cognitive-behavioural therapy intervention for child anxiety disorders. Journal of Pediatric Psychology, 34, 474–487.
Masi, G., Millepiedi, S., Perugi, G., Pfanner, C., Berloffa, S., Pari, C., et al. (2009). Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. CNS Drugs, 23, 241–252.
National Institute of Mental Health. (1985). CGI (Clinical Global Impression) scale-NIMH. Psychopharmacology Bulletin, 21, 839–844.
Pediatric OCD Treatment Study Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive compulsive disorder. Journal of the American Medical Association, 292, 1969–1976.
Piacentini, J., Bergman, R. L., Keller, M., & McCracken, J. T. (2003). Functional impairment in children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 13S–1, S61–S69.
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). The Children’s Yale-Brown Obsessive-Compulsive Scale: reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–853.
Spence, S. H., Holmes, J. M., March, S., & Lipp, O. V. (2006). The feasibility and outcome of clinic plus internet delivery of cognitive-behavior therapy for childhood anxiety. Journal of Consulting and Clinical Psychology, 74, 614–621.
State, M. W., Dykens, E. M., Rosner, B., Martin, A., & King, B. H. (1999). Obsessive-compulsive symptoms in Prader-Willi and “Prader-Willi-Like” patients. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 329–334.
Storch, E. A., Murphy, T. K., Geffken, G. R., Soto, O., Sajid, M., Allen, P., et al. (2004). Psychometric evaluation of the Children’s Yale-Brown Obsessive Compulsive Scale. Psychiatry Research, 129, 91–98.
Storch, E. A., Geffken, G. R., Merlo, L., Mann, G., Duke, D., Munson, M., et al. (2007). Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 469–478.
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363, 1341–1345.
Wigren, M., & Hansen, S. (2003). Rituals and compulsivity in Prader-Willi syndrome: profile and stability. Journal of Intellectual Disability Research, 47, 428–438.
Wigren, M., & Hansen, S. (2005). ADHD symptoms and insistence on sameness in Prader-Willi syndrome. Journal of Intellectual Disability Research, 49, 449–456.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was funded by a grant to the first author from the Foundation for Prader Willi Research. The contributions of Danielle Bodzin, B.S., Daniel Driscoll, M.D., Ph.D., Amy Parks, Psy.D., and Theresa Strong, Ph.D. are noted.
Rights and permissions
About this article
Cite this article
Storch, E.A., Rahman, O., Morgan, J. et al. Case Series of Behavioral Psychotherapy for Obsessive-Compulsive Symptoms in Youth with Prader-Willi Syndrome. J Dev Phys Disabil 23, 359–368 (2011). https://doi.org/10.1007/s10882-011-9233-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10882-011-9233-5